LEADER 03307nam  2200409   450 
001 9910647224203321
005 20230324055403.0
010   $a3-0365-5764-4
035   $a(CKB)5680000000300105
035   $a(NjHacI)995680000000300105
035   $a(EXLCZ)995680000000300105
100   $a20230324d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aEndocrine and Neuroendocrine Cancers /$fAlfredo Berruti, Vito Amoroso, Nicola Fazio, editors
210  1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource (198 pages)
311   $a3-0365-5763-6 
327   $aPreface to "Endocrine and Neuroendocrine Cancers" vii -- Endocrine and Neuroendocrine Tumors: A Special Issue 1 -- Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes 5 -- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise 19 -- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy 39 -- Molecular Profiling o f Well-Differentiated N euroendocrine T umours: T he R ole o f c tDNA in Real-World Practice 53 -- Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT 63 -- Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia 75 -- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 89 -- Anaplastic Thyroid Carcinoma: An Update 103 -- Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency 129 -- Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? 143 -- Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials 159 -- Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A -- Systematic Review 177.
330   $aEndocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available.  This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives.
606   $aNeuroendocrine tumors
606   $aNeuroendocrinology
615  0$aNeuroendocrine tumors.
615  0$aNeuroendocrinology.
676   $a616.9944
702   $aFazio$b Nicola
702   $aAmoroso$b Vito
702   $aBerruti$b Alfredo
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910647224203321
996   $aEndocrine and Neuroendocrine Cancers$93018132
997   $aUNINA